Website
http://dataportal.arc.gov.au/NCGP/API/grants/DP0986292
Funding Status
Closed
Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the Feedback Form.
Funded Activity Summary
Structure-based design of anti-osteoporotic drug leads: an integrated approach. One of the major consequences of Australia's aging population is that age-related diseases, such as osteoporosis, are increasing. Apart from the significant human suffering caused by this disease, there is an immense financial burden on the community, patients and their families. Current treatments for osteoporosis are often ineffective and also have major side-effects. An enzyme has been identified which plays a crucial role in the progression of this disease by increasing the rate of bone-thinning. We will make compounds to slow down this enzyme. This project will provide the basis for the future development of new and improved drugs to treat osteoporosis.Funded Activity Details
Start Date: 2009
End Date: 07-2012
Funding Scheme: Discovery Projects
Funding Amount: $350,000.00
Funder: Australian Research Council
Research Topics
ANZSRC Field of Research (FoR)
Enzymes | Bioinorganic Chemistry | Biochemistry and Cell Biology | Biological And Medical Chemistry |
ANZSRC Socio-Economic Objective (SEO)
Skeletal system and disorders (incl. arthritis) | Treatments (e.g. chemicals, antibiotics) | Chemical sciences
